AGP Picks
View all

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on September 24, 2026

Parents in Distress: New Survey Highlights the Impact of Lost Sleep on Busy Parents
Soda Horse Peak Gummies Introduces Horse Peak Soda Multi-Ingredient Dietary Supplement for Male Performance Support
Avaí Bio and Austrianova Present Encapsulated Cell Approach to Sustained α-Klotho Delivery at 2026 Klotho Conference
Elliston Health Launches Concierge Medicine for Adults in New York City
Abercrombie & Fitch’s Activewear Brand, YPB Launches Multi-Season Partnership with Barry’s
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
Applied Biologics Announces Publication of New XWRAP® Translational Research Demonstrating More Favorable Wound-Healing Biology
HCW Biologics Announces Pricing of $1.5 Million Private Placement
Seed Oil-Free Dressings Market Forecast To Hit $1.89Billion By 2030 Amid Strong Industry Growth
IMUNON Makes the Frontline Case for Phase 3 IMNN-001 Study: 14.7-Month OS Signal, Historical IL-12 Safety Barriers Overcome, Enrolling Ahead of Plan
Boehringer Ingelheim and WHO Foundation launch global collaboration to close the gap in obesity and metabolic health
SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing γδ T Cells Target Chemotherapy-Resistant Glioblastoma
Senior Innovation Recognizes Vital Fjord’s UpRiser As The 2026 “Bathroom Safety Product of the Year”
Claris Bio Establishes Corporate Headquarters in San Francisco
Cronos Hosts 2026 Investor Day
Stingray and Stellantis Expand TuneIn Access in Future Vehicles
Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
Primmune Therapeutics Announces Enrollment Milestone in Phase 2 INFLECTION–003 Study of Polvitolimod HCl in Neoadjuvant Melanoma
Biolinq Shine™ Receives FDA 510(k) Clearance for Over-the-Counter Use
Elicio Therapeutics Announces Late-Breaking Phase 2 AMPLIFY-7P Data Selected for Proffered Paper Oral Presentation at ESMO Congress 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.